Edition:
United Kingdom

IRadimed Corp (IRMD.OQ)

IRMD.OQ on NASDAQ Stock Exchange Capital Market

18.28USD
19 Jul 2019
Change (% chg)

$-0.11 (-0.60%)
Prev Close
$18.39
Open
$18.40
Day's High
$18.85
Day's Low
$18.10
Volume
23,201
Avg. Vol
20,809
52-wk High
$38.70
52-wk Low
$16.89

Latest Key Developments (Source: Significant Developments)

IRadimed Posts Q1 Non-GAAP Earnings Per Share $0.13
Tuesday, 30 Apr 2019 

April 30 (Reuters) - IRadimed Corp ::ORATION ANNOUNCES FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 NON-GAAP EARNINGS PER SHARE $0.13.Q1 GAAP EARNINGS PER SHARE $0.15.Q1 REVENUE $8.4 MILLION VERSUS $7.1 MILLION.SEES FY 2019 NON-GAAP EARNINGS PER SHARE $0.69 TO $0.73.SEES Q2 2019 NON-GAAP EARNINGS PER SHARE $0.14 TO $0.15.SEES Q2 2019 GAAP EARNINGS PER SHARE $0.11 TO $0.12.SEES FY 2019 GAAP EARNINGS PER SHARE $0.60 TO $0.64.SEES FY 2019 REVENUE $38.5 MILLION TO $39.5 MILLION.SEES Q2 2019 REVENUE $8.8 MILLION TO $9.0 MILLION.  Full Article

Iradimed Corp Sees Minor Impact To 2019 Revenue After Temporarily Suspending Shipments Of MRI Compatible Patient Vital Signs Monitoring Systems In Europe
Tuesday, 22 Jan 2019 

Jan 22 (Reuters) - IRadimed Corp ::IRADIMED CORPORATION EXPECTS MINOR IMPACT TO 2019 REVENUE AFTER TEMPORARILY SUSPENDING SHIPMENTS OF MRI COMPATIBLE PATIENT VITAL SIGNS MONITORING SYSTEMS IN EUROPEAN MARKETS.IRADIMED CORP SAYS EXPECTS NEGATIVE IMPACT TO FULL-YEAR 2019 REVENUE OF APPROXIMATELY TWO PERCENT.IRADIMED CORP SAYS TEMPORARILY SUSPENDED SALES OF 3880 MRI COMPATIBLE PATIENT VITAL SIGNS MONITORING SYSTEMS IN EUROPEAN COMMISSION MARKETS.IRADIMED-AFTER CONSIDERING SUSPENDING SHIPMENTS OF MRI COMPATIBLE PATIENT VITAL SIGNS MONITORING SYSTEMS IMPACT, STILL EXPECT MID 20 PERCENT REVENUE GROWTH IN 2019.  Full Article

Iradimed Reports Q3 GAAP Earnings Per Share $0.20
Tuesday, 30 Oct 2018 

Oct 30 (Reuters) - IRadimed Corp ::IRADIMED CORPORATION ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 NON-GAAP EARNINGS PER SHARE $0.14.Q3 GAAP EARNINGS PER SHARE $0.20.Q3 REVENUE $7.6 MILLION VERSUS $5.7 MILLION.SEES Q4 2018 NON-GAAP EARNINGS PER SHARE $0.12 TO $0.13.SEES Q4 2018 GAAP EARNINGS PER SHARE $0.09 TO $0.10.SEES Q4 2018 REVENUE $7.9 MILLION TO $8.1 MILLION.SEES FY 2018 GAAP EARNINGS PER SHARE $0.47 - $0.48​.SEES FY 2018 REVENUE $30.0 MILLION - $30.2 MILLION​ .  Full Article

Iradimed Corp Announces Q3 2018 Financial Results
Tuesday, 30 Oct 2018 

Oct 30 (Reuters) - IRadimed Corp ::ORATION ANNOUNCES THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 NON-GAAP EARNINGS PER SHARE $0.14.Q3 GAAP EARNINGS PER SHARE $0.20.Q3 REVENUE $7.6 MILLION VERSUS $5.7 MILLION.SEES Q4 2018 NON-GAAP EARNINGS PER SHARE $0.12 TO $0.13.SEES FY 2018 GAAP EARNINGS PER SHARE $0.35 TO $0.37.SEES Q4 2018 GAAP EARNINGS PER SHARE $0.09 TO $0.10.SEES FY 2018 REVENUE $29.5 MILLION TO $30.1 MILLION.SEES Q4 2018 REVENUE $7.9 MILLION TO $8.1 MILLION.  Full Article

IRadimed Corp Q2 Non-GAAP Earnings Per Share $0.14
Tuesday, 31 Jul 2018 

July 31 (Reuters) - IRadimed Corp ::IRADIMED CORPORATION ANNOUNCES SECOND QUARTER 2018 FINANCIAL RESULTS.Q2 REVENUE $7.4 MILLION VERSUS $5.5 MILLION.Q2 NON-GAAP EARNINGS PER SHARE $0.14.Q2 GAAP EARNINGS PER SHARE $0.11.SEES Q3 2018 REVENUE $7.4 MILLION TO $7.5 MILLION.SEES Q3 2018 GAAP EARNINGS PER SHARE $0.07 TO $0.08.SEES FY 2018 REVENUE $29.5 MILLION TO $30.1 MILLION.SEES FY 2018 GAAP EARNINGS PER SHARE $0.35 TO $0.37.SEES Q3 2018 NON-GAAP EARNINGS PER SHARE $0.09 TO $0.10.SEES FY 2018 ADJUSTED EARNINGS PER SHARE $0.45 TO $0.47.  Full Article

Iradimed Corporation Q4 EPS $0.02
Tuesday, 6 Feb 2018 

Feb 6 (Reuters) - Iradimed Corp ::IRADIMED CORPORATION ANNOUNCES FOURTH QUARTER 2017 FINANCIAL RESULTS.Q4 NON-GAAP EARNINGS PER SHARE $0.10.Q4 GAAP EARNINGS PER SHARE $0.02.Q4 REVENUE $6.7 MILLION VERSUS $6.0 MILLION.SEES FY 2018 NON-GAAP EARNINGS PER SHARE $0.33 TO $0.38.SEES Q1 2018 NON-GAAP EARNINGS PER SHARE $0.06 TO $0.07.SEES FY 2018 GAAP EARNINGS PER SHARE $0.22 TO $0.27.SEES Q1 2018 GAAP EARNINGS PER SHARE $0.04 TO $0.05.SEES FY 2018 REVENUE $29.3 MILLION TO $30 MILLION.SEES Q1 2018 REVENUE $6.8 MILLION TO $6.9 MILLION.‍NET INCOME FOR Q4 AND FULL YEAR 2017 WAS NEGATIVELY IMPACTED AS A RESULT OF TAX CUTS AND JOBS ACT​.‍REDUCTION IN U.S. FEDERAL CORPORATE TAX RATE EXPECTED TO POSITIVELY IMPACT IRADIMED'S FUTURE EARNINGS​.  Full Article

Iradimed Corporation says Q3 GAAP earnings per share $0.02
Monday, 30 Oct 2017 

Oct 30 (Reuters) - Iradimed Corp -:Iradimed corporation announces third quarter 2017 financial results.Q3 non-GAAP earnings per share $0.07.Q3 GAAP earnings per share $0.02.Q3 revenue $5.7 million versus $7.7 million.Sees Q4 2017 non-GAAP earnings per share $0.05 to $0.06.Raises FY 2017 non-GAAP earnings per share view to $0.17 to $0.18.Sees Q4 2017 GAAP earnings per share $0.00 to $0.02.Sees Q4 2017 revenue about $6.3 million to $6.7 million.  Full Article

Iradimed announces FDA 510(k) nod for MRI compatible patient vital signs monitor
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Iradimed Corp :Iradimed corporation announces fda 510(k) clearance of MRI compatible patient vital signs monitor.  Full Article